Back to top
more

Merit Medical Systems (MMSI)

(Delayed Data from NSDQ)

$94.35 USD

94.35
239,975

+0.59 (0.63%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $94.34 -0.01 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 26% (186 out of 250)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Here's Why You Should Retain Integer Holdings (ITGR) Stock Now

by Zacks Equity Research

Integer Holdings (ITGR) continues to gain traction from portfolio management. However, intense competition is a woe.

Merit Medical Systems (MMSI) Sees Hammer Chart Pattern: Time to Buy?

by Zacks Equity Research

Merit Medical Systems (MMSI) has been struggling lately, but the selling pressure may be coming to an end soon.

OPKO Health's (OPK) BioReference Starts Fan Testing Program

by Zacks Equity Research

OPKO Health's (OPK) BioReference commences mandatory, large-scale COVID-19 testing programs for fans for AFC Division Wild Card playoff game.

Here's Why You Should Hold on to Cerner (CERN) Stock Now

by Zacks Equity Research

Cerner (CERN) continues to gain from solid prospects in EHR and strategic deals. However, intense competition remains a woe.

    Here's Why You Should Hold on to Intuitive Surgical (ISRG) Now

    by Zacks Equity Research

    Intuitive Surgical (ISRG) continues to gain traction from improving adoption of da Vinci Surgical System. But weak operational performance is a woe.

    Nevro's (NVRO) FDA Submission to Treat Patients With PDN

    by Zacks Equity Research

    Nevro's (NVRO) submission of a pre-market approval supplement to the FDA to seek approval for its Senza System can help in the treatment of chronic pain associated with PDN.

    Why You Must Add Merit Medical (MMSI) Stock to Your Portfolio

    by Zacks Equity Research

    Investor optimism is high on Merit Medical (MMSI) stock, courtesy of solid prospects.

    HMS Holdings (HMSY) to be Acquired by Gainwell for $3.4B

    by Zacks Equity Research

    HMS Holdings (HMSY) entered into an agreement to be acquired by Gainwell in an all-cash transaction deal worth about $3.4 billion.

    Here's Why You Should Retain Cooper Companies (COO) Stock

    by Zacks Equity Research

    Cooper Companies (COO) continues to benefit from solid CVI and CSI product portfolios.

    Intersect ENT (XENT) Banks on SINUVA Sales Amid COVID-19 Woes

    by Zacks Equity Research

    Intersect ENT's (XENT) potential in chronic sinusitis market and progress in SINUVA and PROPEL product lines are encouraging.

    Masimo's (MASI) Telehealth Solution Helps in COVID-19 Crisis

    by Zacks Equity Research

    Masimo (MASI) is lending support to Renown Health through Masimo SafetyNet in order to manage the COVID-19 surge.

    Here's Why You Should Retain AmerisourceBergen (ABC) Now

    by Zacks Equity Research

    AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches.

    Abiomed's (ABMD) ECMO Technology Completes Successful Treatment

    by Zacks Equity Research

    Abiomed (ABMD) successfully treats first two patients in the world with the help of its Breethe OXY-1 System.

    Here's Why You Should Retain Stryker Stock Right Now

    by Zacks Equity Research

    Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises concern.

    NextGen (NXGN) Solutions Support COVID-19 Vaccine Distribution

    by Zacks Equity Research

    NextGen (NXGN) lends a hand to the nationwide rollout of COVID-19 vaccines through its robust EHR platform and integrated solutions.

    IDEXX (IDXX) Gains on CAG Sales, Global Growth Remains Robust

    by Zacks Equity Research

    IDEXX (IDXX) sees sturdy gains in CAG Diagnostics recurring revenues, supported by high organic gains in both U.S. and International markets.

    Syneos Health (SYNH) Buys Illingworth Research, Expands CRO Base

    by Zacks Equity Research

    Syneos Health (SYNH) is currently working on bringing greater flexibility to each customer study, based on data, people, process and technology.

      Globus Medical (GMED) Gains From Robot Sales Amid Pandemic Blues

      by Zacks Equity Research

      Globus Medical (GMED) saw a visible rebound in its revenue trend in the third quarter.

      Abbott (ABT) Broadens Pediatric Client Base With New Labeling

      by Zacks Equity Research

      Abbott's (ABT) HeartMate 3 LVAD or heart pump is an implantable device that pumps blood through the body in people whose hearts are too weak to do so naturally.

      Cerner (CERN) to Buy Kantar Health to Enhance Clinical Research

      by Zacks Equity Research

      Cerner (CERN) agrees to acquire Kantar Health to drive safety and efficiency of clinical research across life sciences, pharmaceuticals and health care.

      Here's Why You Should Retain AMN Healthcare (AMN) Stock Now

      by Zacks Equity Research

      AMN Healthcare (AMN) continues to gain traction from its wide range of services, and Healthcare MSP. Intense competition remains a woe.

        NextGen's (NXGN) HDH to Facilitate Health Information Exchange

        by Zacks Equity Research

        NextGen's (NXGN) HDH has been chosen by HI-BRIDGE HIE for secure sharing of patient health data from multiple sources.

          Here's Why You Should Retain Fresenius Medical (FMS) Stock

          by Zacks Equity Research

          Fresenius Medical (FMS) continues to gain traction from its broad range of dialysis products and services. However, intense competition remains a woe.

          Cerner's (CERN) Simplified Digital Tools to Aid Health Systems

          by Zacks Equity Research

          Cerner (CERN) offers centralized digital ordering and monitoring for clients in order to help health systems.

          Here's Why You Should Hold on to McKesson (MCK) Stock Now

          by Zacks Equity Research

          McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.